Concepedia

Brad Foulk

BF

Statistics

Publications

9

Citations

540

H-Index

9

Active since

2011

Affiliations

Janssen (United States)(Current)

The University of Melbourne

Janssen (Belgium)

Duke University

Duke Medical Center

Brad Foulk is an author at Janssen (United States) specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

2011–2025

9

Publications

9

Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab

Tineke Casneuf, Homer Adams, Niels W.C.J. van de Donk et al. · Leukemia · 2020 · 117 citations · Full text

, , +17

CAR+ T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma

Simon J. Harrison, Tamia Nguyen, Marzia Rahman et al. · Blood · 2023 · 97 citations

, , +12

Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC)

Sumanta K. Pal, Jaymala Patel, Miaoling He et al. · Cancer · 2017 · 88 citations · Full text

, , +17

CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma

Simon J. Harrison, Cyrille Touzeau, Nicolas Kint et al. · New England Journal of Medicine · 2025 · 51 citations

, , +17

Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders

Brad Foulk, Mike Schaffer, Steve Gross et al. · British Journal of Haematology · 2017 · 48 citations

, , +14

1–5 of 9